Entest Biomedical In (ENTB) 0.0002 $ENTB Entest
Post# of 273257
Posted On: 07/11/2015 6:31:37 PM
Entest Biomedical In (ENTB) 0.0002 $ENTB
Entest BioMedical, Inc. in Discussions to Acquire Nanotechnology Delivery System for Cancer Therapy
Marketwired - Mon Jun 01, 10:00AM CDT
Entest BioMedical Inc. (OTC PINK: ENTB) announced today that the Company is currently in discussions to acquire a nanotechnology for the delivery of cancer therapeutics in both animals and humans.
Entest BioMedical Inc. Recruits Salk Institute Researcher to Lead Cancer Stem Cell Program for Treating Feline Leukemia and Canine Cancer
Marketwire - Wed Jul 16, 9:00AM CDT
Entest BioMedical Inc. (PINKSHEETS: ENTB)
Entest BioMedical, Inc. in Discussions to Acquire Nanotechnology Delivery System for Cancer Therapy
Marketwired - Mon Jun 01, 10:00AM CDT
Entest BioMedical Inc. (OTC PINK: ENTB) announced today that the Company is currently in discussions to acquire a nanotechnology for the delivery of cancer therapeutics in both animals and humans.
Entest BioMedical Inc. Recruits Salk Institute Researcher to Lead Cancer Stem Cell Program for Treating Feline Leukemia and Canine Cancer
Marketwire - Wed Jul 16, 9:00AM CDT
Entest BioMedical Inc. (PINKSHEETS: ENTB)
(0)
(0)Scroll down for more posts ▼